FDA Guidance: Using EHRs and Medical Claims Data to support drug and biological products regulation
The FDA has published guidance as part of its [...]
Landscape review of the UKRI data research infrastructure
UK Research and Innovation (UKRI), including the seven research [...]
Identifying opportunities and understanding the benefits of pathway optimisation
CF worked on behalf of a global pharmaceutical company [...]
Improving the cancer pathway from the impact of Covid-19
CF has been working with a large international pharmaceutical client [...]
